PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.06%
Revenue growth under 50% of QRVO's 27.69%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.38%
Gross profit growth under 50% of QRVO's 49.33%. Michael Burry would be concerned about a severe competitive disadvantage.
10.11%
EBIT growth below 50% of QRVO's 189.01%. Michael Burry would suspect deeper competitive or cost structure issues.
9.21%
Operating income growth under 50% of QRVO's 570.87%. Michael Burry would be concerned about deeper cost or sales issues.
7.23%
Net income growth under 50% of QRVO's 206.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
6.98%
EPS growth under 50% of QRVO's 208.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.94%
Diluted EPS growth under 50% of QRVO's 204.17%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.31%
Reduced diluted shares while QRVO is at 1.86%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.06%
Dividend reduction while QRVO stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
62.24%
OCF growth under 50% of QRVO's 185.06%. Michael Burry might suspect questionable revenue recognition or rising costs.
76.64%
FCF growth under 50% of QRVO's 355.70%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
101.87%
10Y revenue/share CAGR at 75-90% of QRVO's 131.30%. Bill Ackman would press for new markets or product lines to narrow the gap.
27.36%
5Y revenue/share CAGR under 50% of QRVO's 67.65%. Michael Burry would suspect a significant competitive gap or product weakness.
20.00%
3Y revenue/share CAGR under 50% of QRVO's 40.77%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
336.00%
10Y OCF/share CAGR under 50% of QRVO's 6046.15%. Michael Burry would worry about a persistent underperformance in cash creation.
164.88%
Below 50% of QRVO's 487.44%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
79.90%
3Y OCF/share CAGR above 1.5x QRVO's 43.29%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
578.69%
Net income/share CAGR above 1.5x QRVO's 206.91% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
118.39%
5Y net income/share CAGR at 50-75% of QRVO's 220.72%. Martin Whitman might see a shortfall in operational efficiency or brand power.
70.62%
Below 50% of QRVO's 713.20%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
24.55%
Below 50% of QRVO's 682.97%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.32%
Negative 5Y equity/share growth while QRVO is at 319.17%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-8.78%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
602.36%
Dividend/share CAGR of 602.36% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
155.50%
Dividend/share CAGR of 155.50% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.39%
Below 50% of QRVO's 469.38%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-1.46%
Firm’s AR is declining while QRVO shows 27.85%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.44%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.34%
Negative asset growth while QRVO invests at 2.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.17%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.10%
Debt shrinking faster vs. QRVO's 31.67%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
0.26%
R&D dropping or stable vs. QRVO's 5.27%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.45%
SG&A growth well above QRVO's 2.63%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.